Catechins for the treatment of fibrillogenesis in Alzheimer's disease, Parkinson's disease, systemic AA amyloidosis and other amyloid disorders

摘要

The use of a catechin in the manufacture of a medicament for treating Parkinson's disease or laenfermedad Lewy body where the catechin is selected from the group consisting of catechin, epicatechin, gallocatechin gallate, epigallocatechin gallate, epigallocatechin gallate epicatechin, and pharmaceutically acceptable Lassales of the foregoing catechins.